ProPharma Group Acquires The Weinberg Group

January 28, 2019

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired The Weinberg Group, a Washington, D.C.-based regulatory and compliance consultancy serving the pharmaceutical, biotech, and medical device industries. The deal expands ProPharma's pre-approval and pre-clinical regulatory capabilities and further integrates Weinberg's FDA-focused regulatory expertise into ProPharma's global life sciences compliance platform.

Buyers
ProPharma Group, Linden Capital Partners
Targets
The Weinberg Group Inc.
Platforms
ProPharma Group
Location
District of Columbia, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.